Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adamas Pharmaceuticals
Adamas Pharmaceuticals
(ADMS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Gocovri
Amantadine
2017-08-24
2025-2038
Drug-induced akathisia
,
Drug-induced dyskinesia
,
Dystonia
,
Human influenza
,
Parkinson disease
,
Secondary parkinson disease
Osmolex
Amantadine
2018-02-16
2025-2038
Drug-induced akathisia
,
Drug-induced dyskinesia
,
Dystonia
,
Human influenza
,
Parkinson disease
,
Secondary parkinson disease
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Amantadine
human influenza
,
dyskinesias
,
multiple sclerosis
,
parkinson disease
Sodium lactate
human influenza
Microcrystalline cellulose
human influenza
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use